Browse Category

Rocket Lab News 16 January 2026 - 6 February 2026

Rocket Lab stock slides again; RKLB ends down 9% as investors eye earnings and Washington risk

Rocket Lab stock slides again; RKLB ends down 9% as investors eye earnings and Washington risk

Rocket Lab shares fell 9.3% to $66.32 Thursday, then slid another 6% after hours, extending losses to 18% since Tuesday. The drop followed two sharp sell-offs after a brief rally tied to SpaceX-xAI news and was compounded by Congress rejecting NASA Mars mission funding. Investors now await Rocket Lab’s earnings report on Feb. 26.
Rocket Lab stock slides again as RKLB pulls back from January highs

Rocket Lab stock slides again as RKLB pulls back from January highs

Rocket Lab shares fell 5.35% to $75.79 by Monday afternoon, extending losses to 24% below their January high. The drop follows reports that Congress pulled funding for NASA’s Mars Sample Return mission, for which Rocket Lab had proposed a $4 billion role. Investors remain focused on the company’s dependence on government contracts and delays in its Neutron rocket program. Rocket Lab will report Q4 and full-year results on Feb. 26.
Rocket Lab stock price drops 6.6% and hangs near $80 after the bell — what to watch c

Rocket Lab stock price drops 6.6% and hangs near $80 after the bell — what to watch c

Rocket Lab shares fell 6.55% Friday to $80.07 before stabilizing near $80 in after-hours trading. The drop followed the company’s 81st Electron launch, sending NEONSAT-1A into orbit. Investors await the Feb. 26 earnings report for updates on the delayed Neutron rocket, after a Stage 1 tank rupture during testing. Broader markets also slid after Trump named Kevin Warsh as Fed pick and inflation data beat forecasts.
31 January 2026
Rocket Lab stock price falls as RKLB slips on Neutron schedule focus ahead of Feb. 26 results

Rocket Lab stock price falls as RKLB slips on Neutron schedule focus ahead of Feb. 26 results

Rocket Lab shares fell 3.1% to $85.84 as the Nasdaq dropped 1.4% Thursday afternoon. Investors tracked the arrival of Neutron’s “Hungry Hippo” hardware in Virginia and awaited a Feb. 26 earnings update for new launch timing. The company is reviewing a recent Stage 1 tank rupture that could affect Neutron’s schedule. Implied volatility on Rocket Lab options rose to 97.48, signaling expectations of sharp price swings.
Rocket Lab stock jumps, but Neutron setback keeps investors on edge ahead of February results

Rocket Lab stock jumps, but Neutron setback keeps investors on edge ahead of February results

Rocket Lab shares rose 8% Tuesday before slipping after hours, following a recent Neutron Stage 1 tank rupture that cast uncertainty on the rocket’s launch timeline. The stock traded near $87, up from $80.48, after rebounding from a 9.5% drop Monday. Investors await the late-February earnings call for updates on the Neutron program. The company also secured an $816 million U.S. defense contract.
Rocket Lab stock jumps on “Hungry Hippo” Neutron fairing delivery as Feb. 26 earnings loom

Rocket Lab stock jumps on “Hungry Hippo” Neutron fairing delivery as Feb. 26 earnings loom

Rocket Lab shares rose 5.7% to $85.06 Tuesday after the company announced its “Hungry Hippo” Neutron rocket fairing arrived at Wallops Island, Virginia. The stock rebounded from a nearly 10% drop the previous day. Investors remain focused on Neutron’s first-flight timeline after a recent tank rupture during testing. Rocket Lab will report earnings after markets close on Feb. 26.
Rocket Lab stock price slides as Neutron tank rupture clouds 2026 launch plans

Rocket Lab stock price slides as Neutron tank rupture clouds 2026 launch plans

Rocket Lab shares fell 6.6% to $83.06 by midday Monday after a first-stage tank ruptured during Neutron rocket testing. The company is reviewing test data and will update its launch schedule during its February earnings call. Shares remain up 26% year-to-date despite the setback. Investors are watching for delays to Neutron’s debut, originally targeted for early 2026.
Rocket Lab stock price today: RKLB slips after hours as Neutron tank test rupture keeps timeline in focus

Rocket Lab stock price today: RKLB slips after hours as Neutron tank test rupture keeps timeline in focus

Rocket Lab shares closed up 1.1% at $88.90 Friday, then slipped 0.4% after hours following news of a Stage 1 tank rupture during Neutron rocket testing. The company is assessing possible schedule impacts. Earlier, Rocket Lab completed its first Electron launch of 2026 and plans another mission next week. Director Jon Olson sold 15,205 shares on Jan. 20 under a pre-arranged plan.
Rocket Lab stock rebounds as Neutron test rupture hangs over 2026 debut

Rocket Lab stock rebounds as Neutron test rupture hangs over 2026 debut

Rocket Lab shares rose 3.1% to $90.72 by late Friday morning after a Stage 1 tank rupture during Neutron rocket testing raised concerns about launch delays. The company is reviewing test data to assess impacts on its schedule, with an update expected during its February earnings call. Director Jon A. Olson sold 15,205 shares on Jan. 20, retaining 345,630. Rocket Lab completed its 80th Electron launch this week.
Rocket Lab stock slides as analysts lift targets — what RKLB traders are watching next

Rocket Lab stock slides as analysts lift targets — what RKLB traders are watching next

Rocket Lab shares fell 3.9% to $92.60 by late morning Tuesday, tracking declines in the S&P 500 and Nasdaq. BofA doubled its price target to $120 while Goldman Sachs raised its target to $69 but kept a neutral rating. Shares traded between $91.60 and $98.27, below their 52-week high. Rocket Lab’s next earnings report is expected after the close on Feb. 26.
20 January 2026
Rocket Lab stock slips in premarket after Goldman target hike as tariff jitters hit futures

Rocket Lab stock slips in premarket after Goldman target hike as tariff jitters hit futures

Rocket Lab shares fell 3.6% to $92.86 in early Tuesday trading after closing near record highs Friday. Goldman Sachs raised its price target to $69 but kept a Neutral rating, citing momentum in defense tech. S&P 500 and Nasdaq futures dropped on tariff concerns, weighing on sentiment. Investors await Rocket Lab’s next earnings report on February 26.
20 January 2026
Rocket Lab stock jumps after Morgan Stanley upgrade, new $105 target puts RKLB back in play

Rocket Lab stock jumps after Morgan Stanley upgrade, new $105 target puts RKLB back in play

Rocket Lab USA shares rose 6.1% to $96.30 Friday after Morgan Stanley upgraded the stock to Overweight and raised its price target to $105. The stock gained another 0.5% in after-hours trading. Director Merline Saintil sold 108,500 shares this week at prices between $86.58 and $90, according to SEC filings. Rocket Lab’s next earnings report is expected around Feb. 26.
16 January 2026
Rocket Lab stock jumps on Morgan Stanley upgrade as KeyBanc warns the rally may be “priced in”

Rocket Lab stock jumps on Morgan Stanley upgrade as KeyBanc warns the rally may be “priced in”

Morgan Stanley upgraded Rocket Lab to “overweight” and raised its price target from $67 to $105, sending shares up 6% to $96 on Friday. KeyBanc downgraded the stock to “sector weight,” citing valuation concerns and uncertainty over the Neutron rocket’s launch timeline. Investors are watching Neutron’s inaugural flight as Rocket Lab’s market cap hit $48 billion.
16 January 2026
1 2 3 4

Stock Market Today

Roivant Sciences stock rockets after brepocitinib Phase 2 win — what ROIV investors watch next

Roivant Sciences stock rockets after brepocitinib Phase 2 win — what ROIV investors watch next

8 February 2026
New York, February 8, 2026, 08:54 EST — Market closed Roivant Sciences Ltd (ROIV.O) shares will be back on watchlists when U.S. trading resumes on Monday after a sharp Friday rally pushed the stock to $25.82 at the close, up 22.14% on the day. Volume topped 24 million shares, far above Roivant’s recent run rate. (Twelve Data) The move followed Roivant’s release of positive Phase 2 results for brepocitinib in cutaneous sarcoidosis, a hard-to-treat inflammatory skin disease, and the company’s statement that it submitted a New Drug Application, or NDA, to the U.S. Food and Drug Administration for brepocitinib in
Applied Digital stock surges 25% to $34.95 — what APLD investors are watching next week

Applied Digital stock surges 25% to $34.95 — what APLD investors are watching next week

8 February 2026
Applied Digital shares surged 25.5% to $34.95 Friday, with 44.7 million shares traded after a volatile session. The move followed renewed interest in AI-linked infrastructure stocks and outpaced gains in peers like Core Scientific and Digital Realty. The company recently reported $126.6 million in quarterly revenue and signed major data center leases with hyperscale clients.
Archer Aviation stock jumps 12% into the weekend as small caps lead — what to watch next

Archer Aviation stock jumps 12% into the weekend as small caps lead — what to watch next

8 February 2026
Archer Aviation shares jumped 12.5% to $7.30 Friday, with 50.5 million shares traded as small-cap stocks rallied and tech lagged. ARK Investment Management disclosed a 5.4% stake in Archer on Feb. 3. The company, which has not posted revenue, remains sensitive to sentiment and funding risks. Traders await U.S. jobs data Feb. 11 and inflation data Feb. 13.
Big Tech’s $630B AI data-center spending surge is squeezing chips, electricians — and investor patience

Big Tech’s $630B AI data-center spending surge is squeezing chips, electricians — and investor patience

8 February 2026
Amazon shares fell 9% Friday after announcing a $200 billion capital spending plan for 2026. Alphabet and Meta also outlined record capex, raising concerns about free cash flow and forcing potential cuts to buybacks or increased borrowing. Investors punished several tech stocks, including Amazon, Alphabet, Meta, ServiceNow, and Salesforce, while Nvidia rose. The surge in AI infrastructure spending is straining supply chains and power capacity.
Go toTop